Coya Therapeutics, Inc. (COYA) vs Genelux Corporation (GNLX)
A side-by-side comparison of Coya Therapeutics, Inc. and Genelux Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.93HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
GNLX
Genelux Corporation
$2.56HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — COYA vs GNLX
growth of $100 · dividends reinvested · last 4yCOYA +5.2% (+1.3%/yr)GNLX -57.7% (-19.4%/yr)COYA compounded faster over this window
COYA GNLX
COYA vs GNLX: by the numbers
- •COYA is the larger company ($116M vs $115M market cap).
- •Both run net losses; COYA's is the smaller (-270.22% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | COYA | GNLX |
|---|---|---|
| P/S ratio | 14.42 | 14345.01 |
| P/B ratio | 0.00 | 7.12 |
Profitability
| Metric | COYA | GNLX |
|---|---|---|
| Gross margin | 99.91% | -7075.00% |
| Operating margin | -255.05% | -415175.00% |
| Net margin | -270.22% | -422412.50% |
| ROE | -0.05% | -209.73% |
| ROIC | -0.05% | -192.18% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.